Richard Lee, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Dendreon
    Date added:
    Date updated:
    12/22/2021
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Dendreon
    Date added:
    Date updated:
    12/22/2021
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Bayer
    Date added:
    Date updated:
    12/22/2021
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Bayer
    Date added:
    Date updated:
    12/22/2021
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Clovis
    Date added:
    Date updated:
    12/22/2021
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Clovis
    Date added:
    Date updated:
    12/22/2021
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Janssen LLC
    Date added:
    Date updated:
    12/22/2021
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Janssen LLC
    Date added:
    Date updated:
    12/22/2021
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Dendreon
    Date added:
    Date updated:
    12/22/2021
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Bayer
    Date added:
    Date updated:
    12/22/2021

Pages

Return to Webinar: Trimodality Therapy for Management of Muscle Invasive Bladder Cancer (2020)